首页> 外文期刊>Journal of Medicinal Chemistry >A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues.
【24h】

A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues.

机译:开发选择性Cdk4抑制剂的新方法:基于Cdk4特定氨基酸残基位置的文库设计。

获取原文
获取原文并翻译 | 示例
           

摘要

Identification of a selective inhibitor for a particular protein kinase without inhibition of other kinases is critical for use as a biological tool or drug. However, this is very difficult because there are hundreds of homologous kinases and their kinase domains including the ATP binding pocket have a common folding pattern. To address this issue, we applied the following structure-based approach for designing selective Cdk4 inhibitors: (1) identification of specifically altered amino acid residues around the ATP binding pocket in Cdk4 by comparison of 390 representative kinases, (2) prediction of appropriate positions to introduce substituents in lead compounds based on the locations of the altered amino acid residues and the binding modes of lead compounds, and (3) library design to interact with the altered amino acid residues supported by de novo design programs. Accordingly, Asp99, Thr102, and Gln98 of Cdk4, which are located in the p16 binding region, were selected as first target residues for specific interactions with Cdk4. Subsequently, the 5-position of the pyrazole ring in the pyrazol-3-ylurea class of lead compound (2a) was predicted to be a suitable position to introduce substituents. We then designed a chemical library of pyrazol-3-ylurea substituted with alkylaminomethyl groups based on the output structures of de novo design programs. Thus we identified a highly selective and potent Cdk4 inhibitor, 15b, substituted with a 5-chloroindan-2-ylaminomethyl group. Compound 15b showed higher selectivity on Cdk4 over those on not only Cdk1/2 (780-fold/190-fold) but also many other kinases (>430-fold) that have been tested thus far. The structural basis for Cdk4 selective inhibition by 15b was analyzed by combining molecular modeling and the X-ray analysis of the Cdk4 mimic Cdk2-inhibitor complex. The results suggest that the hydrogen bond with the carboxyl group of Asp99 and hydrophobic van der Waals contact with the side chains of Thr102 and Gln98 are important. Compound 15b was found to cause cell cycle arrest of the Rb(+) cancer cell line in the G(1) phase, indicating that it is a good biological tool.
机译:鉴定特定蛋白激酶的选择性抑制剂而不抑制其他激酶对于用作生物学工具或药物至关重要。然而,这非常困难,因为存在数百种同源激酶,并且它们的激酶结构域(包括ATP结合口袋)具有共同的折叠模式。为了解决这个问题,我们采用以下基于结构的方法设计选择性Cdk4抑制剂:(1)通过比较390种代表性激酶来鉴定Cdk4中ATP结合口袋周围特异改变的氨基酸残基,(2)预测合适的位置根据改变的氨基酸残基的位置和结合化合物的结合模式在先导化合物中引入取代基,以及(3)库设计以与从头设计程序支持的经改变的氨基酸残基相互作用。因此,选择位于p16结合区的Cdk4的Asp99,Thr102和Gln98作为与Cdk4特异性相互作用的第一靶标残基。随后,预测在铅化合物(2a)的吡唑-3-基脲类中的吡唑环的5位是引入取代基的合适位置。然后,根据从头设计程序的输出结构,设计了被烷基氨基甲基取代的吡唑-3-基脲的化学库。因此,我们确定了一种高选择性和有效的Cdk4抑制剂15b,它被5-氯茚满-2-基氨基甲基取代。化合物15b对Cdk4的选择性不仅对Cdk1 / 2(780倍/ 190倍),而且对迄今为止已测试的许多其他激酶(> 430倍)都显示出更高的选择性。通过结合分子建模和X射线分析Cdk4模拟Cdk2抑制剂复合物,分析了15b对Cdk4选择性抑制的结构基础。结果表明,具有Asp99的羧基的氢键和疏水的范德华与Thr102和Gln98的侧链接触是重要的。发现化合物15b导致Rb(+)癌细胞系在G(1)相中发生细胞周期停滞,表明它是一种良好的生物学工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号